A 58-year-old man from Delhi presents with progressive jaundice for 3 weeks, pale stools, and dark urine. He denies fever or abdominal pain. On examination, he is afebrile, HR 88/min, BP 120/80 mmHg, and has a palpable gallbladder. Laboratory investigations show total bilirubin 8.2 mg/dL (direct 6.8 mg/dL), ALP 320 U/L, GGT 280 U/L, ALT 85 U/L, and INR 1.2. Abdominal ultrasound reveals dilated intrahepatic and extrahepatic bile ducts with a dilated gallbladder but no stones. The common bile duct measures 12 mm. What is the most appropriate next investigation to establish the diagnosis?

Explanation

## Clinical Scenario Analysis This patient presents with **painless progressive jaundice** with a **palpable gallbladder** (Courvoisier sign), dilated bile ducts on ultrasound, and **no gallstones** — a classic presentation of **pancreatic head malignancy** causing biliary obstruction. ## Diagnostic Workup Algorithm ```mermaid flowchart TD A[Obstructive jaundice + Courvoisier sign + No stones on US]:::outcome A --> B{Next step in diagnosis?}:::decision B -->|Visualize biliary tree anatomy| C[MRCP]:::action B -->|Tissue diagnosis needed| D[ERCP with brushings/biopsy]:::action B -->|Assess vascular involvement| E[CT with contrast]:::action C --> F[Defines obstruction level, rules out stones, shows ductal dilatation]:::outcome D --> G[Therapeutic + diagnostic]:::outcome E --> H[Staging, resectability assessment]:::outcome I[Sequence: MRCP first for anatomy, then CT for staging, then ERCP if needed]:::action ``` ## Why MRCP is the Best Next Step **Key Point:** MRCP is the **gold standard non-invasive imaging** for visualizing the entire biliary tree and pancreatic duct system without radiation or endoscopy. **High-Yield:** In a patient with **suspected pancreatic cancer**: 1. **MRCP** defines the level and nature of obstruction (abrupt cutoff vs. gradual narrowing) 2. Shows the **"double duct sign"** (dilated CBD + dilated pancreatic duct) — highly suggestive of pancreatic head mass 3. Avoids premature ERCP (which may cause pancreatitis in an obstructed system) 4. Provides **excellent soft-tissue contrast** to assess mass size and relationship to vessels **Clinical Pearl:** Courvoisier's sign (palpable gallbladder in jaundice) indicates the obstruction is **distal to the cystic duct** — consistent with pancreatic head pathology, not choledocholithiasis. ## Role of Other Investigations | Investigation | Timing | Purpose | |---|---|---| | **MRCP** | First-line | Non-invasive ductal anatomy, rules out stones, defines level of obstruction | | **CT abdomen** | After MRCP | Staging (vascular involvement, metastases, resectability) | | **ERCP** | If tissue needed or therapeutic drainage required | Tissue diagnosis (brushings, biopsy), stent placement | | **PTC** | If ERCP fails or intrahepatic obstruction | Percutaneous drainage, biopsy | **Tip:** The sequence in pancreatic cancer workup is: **MRCP (anatomy) → CT (staging) → ERCP (tissue/therapy if needed)**.